scholarly journals Active Video Games for Rehabilitation in Respiratory Conditions: Systematic Review and Meta-Analysis (Preprint)

2018 ◽  
Author(s):  
Joshua Simmich ◽  
Anthony J Deacon ◽  
Trevor G Russell
Keyword(s):  
Outcome Measures ◽  
Respiratory Diseases ◽  
Meta Analysis ◽  
Mean Difference ◽  
Single Session ◽  
Chronic Respiratory Diseases ◽  
Active Video Games ◽  
Active Video ◽  
Respiratory Conditions

BACKGROUND Exercise and physical activity are key components of treatment for chronic respiratory diseases. However, the level of physical activity and adherence to exercise programs are low in people with these diseases. Active video games (AVGs) may provide a more engaging alternative to traditional forms of exercise. OBJECTIVE This review examines the effectiveness of game-based interventions on physiological outcome measures, as well as adherence and enjoyment in subjects with chronic respiratory diseases. METHODS A systematic search of the literature was conducted, with full texts and abstracts included where they involved an AVG intervention for participants diagnosed with respiratory conditions. A narrative synthesis of included studies was performed. Additionally, meta-analysis comparing AVGs with traditional exercise was undertaken for 4 outcome measures: mean heart rate (HR) during exercise, peripheral blood oxygen saturation (SpO2) during exercise, dyspnea induced by the exercise, and enjoyment of the exercise. RESULTS A total of 13 full-text papers corresponding to 12 studies were included in the review. Interventions predominantly used games released for the Nintendo Wii (8 studies) and Microsoft Xbox Kinect (3 studies). There were 5 studies that examined the acute effects of a single session of AVGs and 7 studies that examined the long-term effects after multiple sessions of AVGs. Trials conducted over more than 1 session varied in duration between 3 and 12 weeks. In these, AVG interventions were associated with either similar or slightly greater improvements in outcomes such as exercise capacity when compared with a traditional exercise control, and they also generally demonstrated improvements over baseline or nonintervention comparators. There were a few studies of unsupervised AVG interventions, but the reported adherence was high and maintained throughout the intervention period. Additionally, AVGs were generally reported to be well liked and considered feasible by participants. For outcome measures measured during a single exercise session, there was no significant difference between an AVG and traditional exercise for HR (mean difference 1.44 beats per minute, 95% CI –14.31 to 17.18), SpO2 (mean difference 1.12 percentage points, 95% CI –1.91 to 4.16), and dyspnea (mean difference 0.43 Borg units, 95% CI –0.79 to 1.66), but AVGs were significantly more enjoyable than traditional exercise (Hedges g standardized mean difference 1.36, 95% CI 0.04-2.68). CONCLUSIONS This review provides evidence that AVG interventions, undertaken for several weeks, can provide similar or greater improvements in exercise capacity and other outcomes as traditional exercise. Within a single session of cardiovascular exercise, an AVG can evoke similar physiological responses as traditional exercise modalities but is more enjoyable to subjects with chronic respiratory diseases. However, there is very limited evidence for adherence and effectiveness in long-term unsupervised trials, which should be the focus of future research.

scholarly journals Active Video Games for Rehabilitation in Respiratory Conditions: Systematic Review and Meta-Analysis

10.2196/10116 ◽  
2019 ◽  
Vol 7 (1) ◽  
pp. e10116 ◽  
Author(s):  
Joshua Simmich ◽  
Anthony J Deacon ◽  
Trevor G Russell
Keyword(s):  
Systematic Review ◽  
Video Games ◽  
Meta Analysis ◽  
Active Video Games ◽  
Active Video ◽  
Respiratory Conditions

Physical Activity in Children and Adolescents With Chronic Respiratory Diseases: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 18 (2) ◽  
pp. 219-229
Author(s):  
Rodrigo Torres-Castro ◽  
Luis Vasconcello-Castillo ◽  
Roberto Acosta-Dighero ◽  
Nicolás Sepúlveda-Cáceres ◽  
Marisol Barros-Poblete ◽  
...  
Keyword(s):  
Physical Activity ◽  
Systematic Review ◽  
Children And Adolescents ◽  
Respiratory Diseases ◽  
Sedentary Time ◽  
Meta Analysis ◽  
Mean Difference ◽  
Slight Reduction ◽  
Healthy Controls ◽  
Chronic Respiratory Diseases

Background: The literature is unclear as to whether children and adolescents with chronic respiratory diseases (CRDs) differ from their healthy peers in physical activity (PA). Objective: To determine the PA levels measured through accelerometers in children and adolescents with CRDs. Methods: The authors conducted a systematic review using five databases. The authors included studies that assessed the PA measured by accelerometers in children and adolescents with CRDs. Two independent reviewers analyzed the studies, extracted the data, and assessed the quality of evidence. Results: From 11,497 reports returned by the initial search, 29 articles reporting on 4381 patients were included. In the sensitivity analysis, the authors found that children and adolescents with CRDs had a moderate-to-vigorous PA (MVPA) of −0.08 hours per day (95% confidence interval [CI], −0.12 to −0.03 h/d; P = .001), which was lower than the healthy controls; the values for sedentary time (mean difference −0.47 h/d; 95% CI, −1.29 to 0.36 h/d; P = .27) and steps/d (mean difference 361 steps/d; 95% CI −385 to 1707 steps/d; P = .45) were similar for both. Conclusion: Children and adolescents with CRDs have a slight reduction in MVPA in comparison with healthy controls, but sedentary time and steps/d were similar for both.

Effects of active video games on children and adolescents: A systematic review with meta‐analysis

2019 ◽  
Vol 30 (1) ◽  
pp. 4-12 ◽  
Author(s):  
Crystian B. Oliveira ◽  
Rafael Z. Pinto ◽  
Bruna T. C. Saraiva ◽  
William R. Tebar ◽  
Leandro D. Delfino ◽  
...  
Keyword(s):  
Systematic Review ◽  
Video Games ◽  
Children And Adolescents ◽  
Meta Analysis ◽  
Active Video Games ◽  
Active Video

scholarly journals Association between Lifetime Tobacco Use and Alcohol Consumption Trajectories and Cardiovascular and Chronic Respiratory Diseases among Older People

2021 ◽  
Vol 18 (21) ◽  
pp. 11275
Author(s):  
Ignacio Madero-Cabib ◽  
Claudia Bambs
Keyword(s):  
Alcohol Consumption ◽  
Older People ◽  
Life Course ◽  
Tobacco Use ◽  
Respiratory Diseases ◽  
Chronic Respiratory Diseases ◽  
Logistic Regression Models ◽  
Improved Design ◽  
The Life Course

Background: We identify representative types of simultaneous tobacco use and alcohol consumption trajectories across the life course and estimate their association with cardiovascular and chronic respiratory diseases (CVDs and CRDs) among older people in Chile. Methods: We used data from a population-representative, face-to-face and longitudinal-retrospective survey focused on people aged 65–75 (N = 802). To reconstruct trajectory types, we employed weighted multichannel sequence analysis. Then, we estimated their associations with CVDs and CRDs through weighted logistic regression models. Results: Long-term exposure to tobacco use and alcohol consumption across life are associated with the highest CVD and CRD risks. Long-term nonsmokers and nondrinkers do not necessarily show the lowest CVDs and CRDs risks if these patterns are accompanied by health risk factors such as obesity or social disadvantages such as lower educational levels. Additionally, trajectories showing regular consumption in one domain but only in specific periods of life, whether early or late, while maintaining little or no consumption across life in the other domain, lead to lower CVDs or CRDs risks than trajectories indicating permanent consumption in both domains. Conclusions: A policy approach that considers CVDs and CRDs as conditions that strongly depend on previous individual experiences in diverse life domains can contribute to the improved design and evaluation of preventive strategies of tobacco use and alcohol consumption across the life course.

Association Between Chronic Respiratory Diseases and Helicobacter pylori: A Meta-Analysis

2015 ◽  
Vol 51 (6) ◽  
pp. 273-278 ◽  
Author(s):  
Lijie Wang ◽  
Yan Guan ◽  
Yan Li ◽  
Xiuju Liu ◽  
Yakun Zhang ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Respiratory Diseases ◽  
Meta Analysis ◽  
Chronic Respiratory Diseases

Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis

2020 ◽  
Author(s):  
Haifeng Shen ◽  
Xin Wang ◽  
Yuntao Nie ◽  
Kai Zhang ◽  
Zihan Wei ◽  
...  
Keyword(s):  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Meta Analysis ◽  
Small Cell ◽  
Mean Difference ◽  
Perioperative Outcomes ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Standardized Mean Difference

Abstract   OBJECTIVES The study aimed to compare the long-term oncological efficacy and perioperative outcomes of patients with locally advanced non-small-cell lung cancers who underwent minimally invasive surgery (MIS) or thoracotomy. METHODS Cochrane Library, PubMed and EMBASE databases, ClinicalTrials.gov and reference lists were searched for relevant studies. Two reviewers independently assessed the quality of the studies. Recurrence-free survival (RFS) and overall survival (OS) and perioperative outcomes were synthesized. Random-effects models were used to summarize hazard ratios (HRs), relative risks and standardized mean differences (SMDs) with 95% confidence intervals (CIs). RESULTS Twenty-three retrospective cohort studies were reviewed with a total of 3281 patients, of whom 1376 (41.9%) received MIS and 1905 (58.1%) received thoracotomy. Meta-analysis showed no significant differences in both RFS (HR, 1.02; 95% CI, 0.89–1.17; P = 0.78) and OS (HR, 0.91; 95% CI, 0.80–1.03; P = 0.15) between MIS versus thoracotomy approaches. Similar results were observed in propensity score matched studies (RFS, HR, 0.94; 95% CI, 0.73–1.20; P = 0.62; OS, HR, 0.96; 95% CI, 0.72–1.30; P = 0.81). No significant difference was found in lymph node clearance and margin positivity. As for perioperative outcomes, MIS was associated with a significant reduction in postoperative complications (relative risk, 0.83; P = 0.01), intraoperative blood loss (standardized mean difference, −0.68; P = 0.007), chest tube drainage (standardized mean difference, −0.38; P = 0.03) and length of hospital stay (standardized mean difference, −0.79; P = 0.002) when compared with thoracotomy. CONCLUSIONS The use of MIS for resectable stage II and III non-small-cell lung cancers is an eligible alternative to conventional thoracotomy without compromising the long-term survival and short-term outcomes.

Magna Ease versus Trifecta Early Hemodynamics

2018 ◽  
Vol 13 (4) ◽  
pp. 267-272 ◽  
Author(s):  
Bobby Yanagawa ◽  
Derrick Y. Tam ◽  
Kathryn Hong ◽  
Amine Mazine ◽  
Akshay Bagai ◽  
...  
Keyword(s):  
Confidence Interval ◽  
Controlled Trial ◽  
Meta Analysis ◽  
Mean Difference ◽  
Effective Orifice Area ◽  
Orifice Area ◽  
Jude Medical ◽  
Long Term Follow Up

Objective This meta-analysis compares the early echocardiographic outcomes of aortic valve replacement using the two most commonly implanted stented bioprostheses. Methods We searched MEDLINE and EMBASE databases until 2017 for studies comparing Magna or Magna Ease (Edwards Lifesciences, Irvine, CA USA) versus Trifecta (St Jude Medical, St. Paul, MN USA) aortic bioprosthetic valves. A random-effects meta-analysis was performed for the primary outcome of mean gradient on echocardiography and secondary outcomes of effective orifice area, indexed effective orifice area, and in-hospital mortality. Results There were two randomized controlled trial, three matched, and six unmatched retrospective observational studies with 2119 patients [median reported follow-up = 6 months (interquartile range = 6 to 12)]. The Magna/Magna Ease valve was associated with higher early mean gradient (mean difference = 4.09, 95% confidence interval = 3.48 to 4.69, P < 0.0001) and smaller effective orifice area (mean difference = 0.30, 95% confidence interval = −0.38 to −0.22, P < 0.0001). There were no differences in 30-day mortality between Magna/Magna Ease and Trifecta (relative risk = 1.01, 95% confidence interval = 0.41 to 2.50, P = 1.0). Conclusions Trifecta may offer a small hemodynamic advantage compared with the Magna/Magna Ease valve with no differences in early mortality. Long-term follow-up is required to determine whether these differences persist and translate into differences in clinical outcomes.

scholarly journals Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials

2013 ◽  
Vol 110 (7) ◽  
pp. 1178-1187 ◽  
Author(s):  
Nassib Bezerra Bueno ◽  
Ingrid Sofia Vieira de Melo ◽  
Suzana Lima de Oliveira ◽  
Terezinha da Rocha Ataide
Keyword(s):  
Body Weight ◽  
Randomised Controlled Trials ◽  
Weighted Mean Difference ◽  
Meta Analysis ◽  
Mean Difference ◽  
Weighted Mean ◽  
Low Fat Diet ◽  
Low Carbohydrate ◽  
Randomised Controlled

The role of very-low-carbohydrate ketogenic diets (VLCKD) in the long-term management of obesity is not well established. The present meta-analysis aimed to investigate whether individuals assigned to a VLCKD (i.e. a diet with no more than 50 g carbohydrates/d) achieve better long-term body weight and cardiovascular risk factor management when compared with individuals assigned to a conventional low-fat diet (LFD; i.e. a restricted-energy diet with less than 30 % of energy from fat). Through August 2012, MEDLINE, CENTRAL, ScienceDirect, Scopus, LILACS, SciELO, ClinicalTrials.gov and grey literature databases were searched, using no date or language restrictions, for randomised controlled trials that assigned adults to a VLCKD or a LFD, with 12 months or more of follow-up. The primary outcome was body weight. The secondary outcomes were TAG, HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), systolic and diastolic blood pressure, glucose, insulin, HbA1c and C-reactive protein levels. A total of thirteen studies met the inclusion/exclusion criteria. In the overall analysis, five outcomes revealed significant results. Individuals assigned to a VLCKD showed decreased body weight (weighted mean difference − 0·91 (95 % CI − 1·65, − 0·17) kg, 1415 patients), TAG (weighted mean difference − 0·18 (95 % CI − 0·27, − 0·08) mmol/l, 1258 patients) and diastolic blood pressure (weighted mean difference − 1·43 (95 % CI − 2·49, − 0·37) mmHg, 1298 patients) while increased HDL-C (weighted mean difference 0·09 (95 % CI 0·06, 0·12) mmol/l, 1257 patients) and LDL-C (weighted mean difference 0·12 (95 % CI 0·04, 0·2) mmol/l, 1255 patients). Individuals assigned to a VLCKD achieve a greater weight loss than those assigned to a LFD in the long term; hence, a VLCKD may be an alternative tool against obesity.

Sign in / Sign up

Export Citation Format

Share Document